Ziopharm Oncology reported $-9788000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Amgen AMGN:US $ 1317M 159M
AstraZeneca AZN:LN 360M 26M
Baxter International BAX:US $ 252M 181M
Biogen BIIB:US $ 1058M 754.2M
Bioline Rx BLRX:US $ -4.93M 0.63M
Bristol Myers Squibb BMY:US $ 1421M 143M
Corcept Therapeutics CORT:US $ 27.41M 4.62M
Curis CRIS:US $ -15.94M 0.17M
Eleven Biotherapeutics EBIO:US $ -0.81M 9.75M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 838M 964M
Immunogen IMGN:US $ -62.02M 37.88M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Johnson & Johnson JNJ:US $ 4814M 335M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Merk MRK:US $ 3944M 366M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Ptc Therapeutics PTCT:US $ -152.09M 25.36M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Verastem VSTM:US $ -21.95M 4.99M
YTE INCY:US $ 161.43M 123.44M
Ziopharm Oncology ZIOP:US $ -9.79M 2.01M